Corteva, Inc. announced its Board of Directors has approved a $145 million capital investment in the Company’s Midland, Mich. manufacturing facility to expand global capacity for the Company’s high-demand insect management technology for the natural products market.
Corteva, Inc. announced its Board of Directors has approved a $145 million capital investment in the Company’s Midland, Mich. manufacturing facility to expand global capacity for the Company’s high-demand insect management technology for the natural products market.
The capacity expansion project was initiated in response to consistently high demand for Corteva’s Spinosyns products, including Spinetoram and Spinosad. Staged to come online over the next few years, the new production will enable Corteva to increase its existing Spinosyns capacity by 30% – addressing the needs of customers in the more than 100 countries into which these solutions are sold around the world for use on more than 100 different crops.
This investment is expected to generate more than $100 million of annual EBITDA for Corteva once fully online.
See full article at Agropages
